[
    {
        "id": "Case503",
        "patient_info": "The 2-year-old is being evaluated for a high-risk brief resolved unexplained event with recurrent witnessed seizure-like episodes, and whole exome sequencing (WES) is being ordered to investigate a possible genetic etiology; chromosomal microarray (CMA) was previously performed and was non-diagnostic. Family history is notable for a parent with consanguinity. The test was ordered by a Nurse Practitioner, the child saw a genetic counselor prior to testing and will have follow-up with the counselor after results are received, and insurance is BCBS_FEP."
    },
    {
        "id": "Case811",
        "patient_info": "A 7-week-old infant is being evaluated for an early-onset movement disorder characterized by dystonia with ataxia and hemiplegia, and chromosomal microarray (CMA) was non-diagnostic so whole exome sequencing (WES) is being pursued; the evaluation was ordered by the general pediatrician, the family reports an affected sibling with multiple congenital anomalies, the patient has BCBS_FEP insurance, and a genetic counselor was seen before testing with plans to return for post-test counseling."
    },
    {
        "id": "Case17",
        "patient_info": "A 4-year-old child is being evaluated for unexplained epileptic encephalopathy with onset before age three and no prior epilepsy multigene panel testing; chromosomal microarray (CMA) was previously performed and was non-diagnostic. The pediatric neurologist is ordering whole exome sequencing (WES) for diagnostic evaluation, and pre-test counseling was discussed with a genetic specialist. There is a family history of an uncle with unexplained developmental regression unrelated to autism or epilepsy, and the family has Cigna insurance."
    },
    {
        "id": "Case884",
        "patient_info": "NO\nThis is a prenatal case (32 weeks\u2019 gestation) described with neurologic/neurodevelopmental abnormalities, which is unrealistic because prenatal scenarios cannot be presented with neurodevelopmental risk."
    },
    {
        "id": "Case647",
        "patient_info": "NO\nA prenatal (17 weeks' gestation) case cannot validly present with developmental regression or other neurodevelopmental features, so the indication is unrealistic."
    },
    {
        "id": "Case710",
        "patient_info": "NO\nA diagnosis of intrauterine fetal demise or stillbirth is incompatible with a 73-year-old patient, so the clinical context and age are inconsistent."
    },
    {
        "id": "Case373",
        "patient_info": "At 25 weeks\u2019 gestation, a fetus is being evaluated for multiple congenital anomalies that do not fit a well-delineated genetic syndrome, and the obstetrician has ordered whole exome sequencing (WES) after prior FISH testing was non-diagnostic; the family history is notable for the patient\u2019s father having had breast cancer and the insurance is UHC."
    },
    {
        "id": "Case120",
        "patient_info": "NO\nThis case is unrealistic because a neonatologist managing a 15-year-old adolescent is not appropriate."
    },
    {
        "id": "Case661",
        "patient_info": "NO\nA 2-week-old neonate cannot have multiple primary breast cancers, so the clinical indication is incompatible with the patient's age."
    },
    {
        "id": "Case13",
        "patient_info": "The patient is a newborn (0 weeks of age) being evaluated for multiple congenital anomalies that do not fit a well-delineated genetic syndrome; prior karyotype testing was non-diagnostic, and the General Pediatrician has ordered whole exome sequencing (WES). The family history is notable for a sibling with unexplained developmental regression unrelated to autism or epilepsy. A genetic counselor saw the family before testing and will provide follow-up counseling after results are received, and the patient\u2019s insurance is BCBS_FEP."
    },
    {
        "id": "Case955",
        "patient_info": "NO\nA 60-year-old adult being managed by a pediatric provider (Pediatric Neurologist) is not allowed under the age\u2013provider rules."
    },
    {
        "id": "Case452",
        "patient_info": "The patient is a 3-week-old neonate being evaluated for a congenital coloboma; the mother has reported dysmorphic features, and prior karyotype testing was non-diagnostic. A Nurse Practitioner has ordered whole exome sequencing (WES) under Cigna, and testing was discussed with a genetic specialist."
    },
    {
        "id": "Case333",
        "patient_info": "NO\nGlobal developmental delay is a pediatric-only diagnosis and is not a realistic clinical indication for a 59-year-old adult."
    },
    {
        "id": "Case457",
        "patient_info": "NO\nA 70-year-old described as having multiple congenital anomalies is unrealistic because congenital anomalies are pediatric-onset findings and this indication is inconsistent with a clearly elderly patient."
    },
    {
        "id": "Case794",
        "patient_info": "NO\nPrenatal testing at 21 weeks\u2019 gestation is not appropriate for an indication of hypotonia or hypertonia in infancy, because prenatal cases cannot be framed as postnatal neurodevelopmental concerns."
    },
    {
        "id": "Case3",
        "patient_info": "The patient is a 17-year-old with a diagnosis of epithelial ovarian/fallopian tube/primary peritoneal carcinoma being evaluated with whole exome sequencing (WES); she has a family history notable for a mother who had breast cancer diagnosed under age 50. Prior FISH testing was non-diagnostic. The test was ordered by a cardiologist, she has seen a genetic counselor multiple times, and the insurance is Cigna."
    },
    {
        "id": "Case160",
        "patient_info": "At 9 years of age, the patient is being evaluated for multiple congenital anomalies and whole exome sequencing (WES) has been ordered after prior FISH testing was non-diagnostic; the family history is notable for a mother with a history of a growth abnormality. The order was placed by a family medicine physician, the family saw a genetic counselor prior to testing, and they will meet again to review results. Insurance for testing is BCBS_FEP."
    },
    {
        "id": "Case556",
        "patient_info": "A 14-year-old adolescent with multiple congenital anomalies is being evaluated by a neurologist who has ordered whole exome sequencing (WES) to investigate an underlying genetic etiology; there has been no prior genetic testing, and the family history is notable for a pathogenic variant in BRCA1, BRCA2, or PALB2 identified in the mother, the evaluation and testing plan were discussed with a genetic specialist with pre-test counseling provided and genetics follow-up planned, and the family\u2019s insurance carrier is UHC."
    },
    {
        "id": "Case542",
        "patient_info": "At 38 weeks' gestation, a fetus is being evaluated for multiple congenital abnormalities affecting several organ systems and prenatal whole exome sequencing (WES) has been ordered by an oncologist after prior FISH testing was non-diagnostic; there is a family history of pancreatic cancer in a maternal uncle, and the pregnancy is covered by UHC."
    },
    {
        "id": "Case805",
        "patient_info": "A 27-year-old patient with multiple congenital anomalies that do not fit a well-delineated genetic syndrome is being evaluated and the primary care physician has ordered whole exome sequencing (WES); the patient has had no prior genetic testing, and family history is notable for a sibling who experienced a brief resolved unexplained event with altered level of responsiveness, cyanosis, pallor, and irregular breathing, the patient has seen a genetic counselor multiple times and will follow up with the counselor after results, and testing will be billed to Cigna."
    },
    {
        "id": "Case499",
        "patient_info": "NO\nA neonatologist managing a 1-year-old is unrealistic because neonatology is limited to the neonatal/infant period under 1 year and care for children \u22651 year is typically by general pediatrics."
    },
    {
        "id": "Case881",
        "patient_info": "A 2-week-old infant is being evaluated for concern for early-onset intellectual disability with a plan for whole genome sequencing (WGS) ordered by the cardiologist after prior FISH testing was non-diagnostic; there is a family history of an older sibling with unexplained developmental regression not attributed to autism or epilepsy, the family saw a genetic counselor prior to testing and will follow up after results are received, and insurance is BCBS_FEP."
    },
    {
        "id": "Case583",
        "patient_info": "A 7-week-old infant is being evaluated for global developmental delay and the Developmental Pediatrician has ordered whole genome sequencing (WGS) with coverage through UHC; prior FISH testing was non-diagnostic and the infant has a sibling with global developmental delay."
    },
    {
        "id": "Case129",
        "patient_info": "The patient is a 12-year-old referred to a neurologist for evaluation of a complex neurodevelopmental disorder with autism spectrum features, and whole genome sequencing (WGS) is being requested after a chromosomal microarray (CMA) was non-diagnostic; there is a family history of Long QT syndrome in the patient\u2019s mother, and the patient\u2019s insurance is UHC."
    },
    {
        "id": "Case681",
        "patient_info": "A 1-year-old is undergoing whole genome sequencing for evaluation of meconium ileus after a chromosomal microarray (CMA) was non-diagnostic; there is a reported family history in the mother of neurologic movement abnormalities described variably as dystonia, ataxia, hemiplegia, or other neuromuscular disorder, the test was ordered by an oncologist, no genetic counselor involvement is documented, and the patient is covered by UHC."
    },
    {
        "id": "Case609",
        "patient_info": "NO\nA neonatologist would not be the appropriate provider for a 15-year-old adolescent, so the provider\u2013age mismatch makes the scenario unrealistic."
    },
    {
        "id": "Case732",
        "patient_info": "The patient is a 19-year-old with a personal history of breast cancer and a mother who was diagnosed with breast cancer before age 50, and the family history also includes a brother with laboratory abnormalities suggestive of an inborn error of metabolism; karyotype testing was previously performed and was non-diagnostic. A pediatric neurologist has ordered whole genome sequencing (WGS), and the patient\u2019s insurance is BCBS_FEP."
    },
    {
        "id": "Case135",
        "patient_info": "NO\nA neonatologist ordering genetic testing for a 1-year-old is implausible because neonatologists manage neonates (<1 year) and are not the appropriate provider for a child of that age."
    },
    {
        "id": "Case837",
        "patient_info": "A 5-year-old child with congenital choanal atresia is being evaluated with whole genome sequencing (WGS) ordered by an oncologist to investigate a potential genetic etiology; prior Fragile X testing was non-diagnostic. The mother has a history of arrhythmia, and insurance coverage is UHC."
    },
    {
        "id": "Case132",
        "patient_info": "This 7-week-old infant is being evaluated for concern for intellectual disability/early developmental delay; the patient\u2019s mother had ovarian carcinoma, and chromosomal microarray (CMA) was previously performed and was non-diagnostic, so the General Pediatrician has ordered whole genome sequencing (WGS) for further etiologic evaluation; the family saw a genetic counselor before testing and will follow up with the counselor after results are received, and the patient\u2019s insurance is UHC."
    },
    {
        "id": "Case887",
        "patient_info": "NO\nThe listed clinical indication (a brief resolved unexplained event/BRUE) is an infant-only diagnosis and is incompatible with the patient's age of 47 years."
    },
    {
        "id": "Case426",
        "patient_info": "A 15-year-old female is being evaluated by a gynecologist for BRCA1/2 testing because she has lobular breast cancer and there is a personal or family history of diffuse gastric cancer; a cousin is reported to have autism spectrum disorder, no prior genetic testing has been performed, and the patient\u2019s insurance is Cigna."
    },
    {
        "id": "Case131",
        "patient_info": "A 3-week-old infant is being evaluated for hypotonia, with a family history notable for a maternal uncle who had moderate-to-severe intellectual disability diagnosed in childhood; prior fluorescence in situ hybridization (FISH) testing was non-diagnostic, and the primary care physician has ordered BRCA1/2 testing, with the family having seen a genetic counselor multiple times; insurance is Cigna."
    },
    {
        "id": "Case251",
        "patient_info": "A 27-year-old patient with congenital choanal atresia, present since birth, is being evaluated by a Family Medicine Physician and has had no prior genetic testing; because the patient's father had metastatic prostate cancer, BRCA1/2 testing has been ordered through UHC for hereditary cancer risk assessment."
    },
    {
        "id": "Case157",
        "patient_info": "The patient is a 1-year-old evaluated by a developmental pediatrician for concerns of moderate to severe intellectual disability, with a sibling reported to have laboratory abnormalities suggestive of an inborn error of metabolism; prior karyotype testing was non-diagnostic, and BRCA1/2 testing has been ordered with coverage listed through UHC."
    },
    {
        "id": "Case836",
        "patient_info": "A 4-week-old infant is being evaluated for Hirschsprung disease and previously underwent chromosomal microarray analysis that was non-diagnostic; the Family Medicine Physician has ordered BRCA1/2 testing, the family reports a sibling with moderate to profound intellectual disability diagnosed by age 18, the parents carry UHC insurance, and the family has seen a genetic counselor multiple times."
    },
    {
        "id": "Case762",
        "patient_info": "NO\nBRCA1/2 testing on a 20 weeks' gestation fetus is unrealistic because prenatal testing is not performed for adult-onset cancer susceptibility."
    },
    {
        "id": "Case979",
        "patient_info": "A 30-year-old man with male breast cancer is undergoing BRCA1/2 testing; prior FISH testing was non-diagnostic, he reports a sibling with an inborn error of metabolism, the test was ordered by his cardiologist, he has seen a genetic counselor multiple times and will continue follow-up with genetics, and his insurance is UHC."
    },
    {
        "id": "Case22",
        "patient_info": "An 18-year-old patient is referred for BRCA1/2 testing because of early-onset, high-risk prostate cancer with metastatic disease and intraductal/cribriform histology, and a father who also had metastatic, high\u2011risk prostate cancer; prior chromosomal microarray analysis (CMA) was non-diagnostic, the test was ordered by a neurologist, the patient saw a genetic counselor before testing and will follow up with genetics after results are returned, and insurance coverage is through BCBS_FEP."
    },
    {
        "id": "Case722",
        "patient_info": "A 35-year-old patient with a reported history of hypotonia in infancy is being referred for BRCA1/2 genetic testing because the patient's mother had two separate primary solid tumors; prior FISH testing was non-diagnostic, the test was ordered by a Nurse Practitioner, and genetic testing was discussed with a genetic specialist, with insurance through BCBS_FEP."
    },
    {
        "id": "Case943",
        "patient_info": "A 5-year-old child is being evaluated for autism spectrum disorder and an isolated single-organ system abnormality, and there is a family history of an inborn error of metabolism in a sibling; prior FISH testing was non-diagnostic. The Family Medicine Physician has ordered BRCA1/2 testing, the family has UHC insurance, and they saw a genetic counselor before testing and will meet again to review results."
    },
    {
        "id": "Case908",
        "patient_info": "A 14-year-old female diagnosed with triple-negative breast cancer is being evaluated for BRCA1/2 testing after prior karyotype testing was non-diagnostic; she has a family history notable for a mother with short stature, the test was ordered by a cardiologist, the patient has declined genetic counseling, and she is insured by Cigna."
    },
    {
        "id": "Case259",
        "patient_info": "The patient is a 1-year-old who presents with congenital coloboma and is being evaluated by a cardiologist; BRCA1/2 testing has been ordered because the mother is reported to carry a known BRCA1, BRCA2, or PALB2 pathogenic/likely pathogenic variant. Fragile X testing was previously performed and was non-diagnostic. The family has UHC insurance, and the parents declined pre-test genetic counseling."
    },
    {
        "id": "Case392",
        "patient_info": "At 4 weeks of age, the infant is being evaluated for a major congenital cardiac anomaly and BRCA1/2 testing has been ordered by a neurologist; prior karyotype testing was non-diagnostic. The family reports a maternal aunt who was diagnosed with colorectal cancer at age 50, a genetic counselor saw the family before testing and will provide follow-up counseling after results are available, and the testing is being submitted under BCBS_FEP."
    },
    {
        "id": "Case99",
        "patient_info": "A 37-year-old patient with a congenital structural anomaly is being evaluated for genetic testing; her mother had unexplained developmental regression unrelated to autism or epilepsy, and no prior genetic testing has been performed. The test ordered by a neurologist is BRCA1/2, the patient saw a genetic counselor before testing and will meet with the counselor again to review results, and the insurance carrier is Cigna."
    },
    {
        "id": "Case628",
        "patient_info": "The patient is a 62-year-old with lifelong unexplained epileptic encephalopathy that began before age three who is being evaluated by a medical geneticist; there has been no prior genetic testing, including no epilepsy multigene panel, and a tumor-focused chromosomal microarray (CMA_tumor) has been ordered. The case was discussed with a genetic specialist and follow-up genetic counseling is planned, there is a reported family history in a sibling of an inborn error of metabolism, and the patient\u2019s insurance is Cigna."
    },
    {
        "id": "Case31",
        "patient_info": "The patient is a 19-year-old who presents with significant hypotonia and has had no prior genetic testing; the evaluation was ordered by a cardiologist and the plan is to perform chromosomal microarray (CMA) for developmental disorders, the patient saw a genetic counselor before testing and will return to the counselor after results are received, insurance is BCBS_FEP, and family history is notable for a maternal aunt with epithelial ovarian cancer."
    },
    {
        "id": "Case418",
        "patient_info": "The 24-year-old patient has epileptic encephalopathy that began in infancy (onset before age three) and is being referred for chromosomal microarray (CMA) testing under BCBS_FEP insurance; there has been no prior genetic testing, the ordering provider is a Nurse Practitioner, the patient declined genetic counseling, and the family history is notable for a mother with Long QT syndrome."
    },
    {
        "id": "Case27",
        "patient_info": "A 69-year-old patient is being evaluated for a progressive movement disorder with prominent dystonia, ataxia, and hemiplegic features; the Family Medicine Physician has ordered chromosomal microarray (CMA) testing after a prior CMA was non-diagnostic. The patient reports a sister with triple-negative breast cancer in the family history, declined pre-test genetic counseling, and the CMA test will be submitted to BCBS_FEP for coverage consideration."
    },
    {
        "id": "Case792",
        "patient_info": "A 19-year-old patient with multiple congenital anomalies present since birth is being evaluated with chromosomal microarray analysis for developmental disorders; prior chromosomal microarray (CMA) testing was non-diagnostic, and the patient has a sibling with global developmental delay, the test was ordered by a family medicine physician, the case was discussed with a genetic specialist, and insurance coverage is through UHC."
    }
]